ARTICLE | Company News
PharmAbcine, 3SBio deal
January 19, 2015 8:00 AM UTC
PharmAbcine granted 3SBio an exclusive license to develop, manufacture and market DIG-KT in Taiwan, Korea and China, including Macau and Hong Kong. PharmAbcine will receive an undisclosed upfront pay...